Page last updated: 2024-08-17

isatin and Leukemia L 1210

isatin has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Damiens, E; Eisenbrand, G; Endicott, JA; Hoessel, R; Lawrie, A; Leclerc, S; Leost, M; Marie, D; Marko, D; Meijer, L; Niederberger, E; Nobel, ME; Tang, W; Tunnah, P	1

Other Studies

1 other study(ies) available for isatin and Leukemia L 1210

Article	Year
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nature cell biology, 1999, Volume: 1, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cell Line; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; HL-60 Cells; Humans; Indigo Carmine; Indoles; Isatin; Jurkat Cells; K562 Cells; Leukemia L1210; Medicine, Chinese Traditional; Mice; Models, Molecular; Molecular Conformation; Protein Conformation; Protein Serine-Threonine Kinases; Recombinant Proteins; Spodoptera; Transfection	1999

Article

Year

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

Nature cell biology, 1999, Volume: 1, Issue:1

Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cell Line; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; HL-60 Cells; Humans; Indigo Carmine; Indoles; Isatin; Jurkat Cells; K562 Cells; Leukemia L1210; Medicine, Chinese Traditional; Mice; Models, Molecular; Molecular Conformation; Protein Conformation; Protein Serine-Threonine Kinases; Recombinant Proteins; Spodoptera; Transfection

1999